The Efficacy and Safety of Imeglimin as Add-On Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy

被引：0
|
作者：
Fouqueray, Pascale
Pirags, Valdis
Inzucchi, Silvio
Bailey, Clifford J.
Schernthaner, Guntram
Diamant, Michaela
Lebovitz, Harold E.
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1004-P
引用
收藏
页码：A257 / A257
页数：1
相关论文
共 50 条
  • [31] The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone
    DeFronzo, Ralph A.
    Hissa, Miguel N.
    Garber, Alan J.
    Gross, Jorge Luiz
    Duan, Raina Yuyan
    Ravichandran, Shoba
    Chen, Roland S.
    DIABETES CARE, 2009, 32 (09) : 1649 - 1655
  • [32] Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes Mellitus
    Masato Odawara
    Izumi Hamada
    Manabu Suzuki
    Diabetes Therapy, 2014, 5 : 169 - 181
  • [33] Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes Mellitus
    Odawara, Masato
    Hamada, Izumi
    Suzuki, Manabu
    DIABETES THERAPY, 2014, 5 (01) : 169 - 181
  • [34] Efficacy and safety of janagliflozin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin alone: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial
    Gao, Leili
    Cheng, Zhifeng
    Su, Benli
    Su, Xiuhai
    Song, Weihong
    Guo, Yushan
    Liao, Lin
    Chen, Xiaowen
    Li, Jiarui
    Tan, Xingrong
    Xu, Fangjiang
    Pang, Shuguang
    Wang, Kun
    Ye, Jun
    Wang, Yuan
    Chen, Lili
    Sun, Jingfang
    Ji, Linong
    DIABETES OBESITY & METABOLISM, 2023, 25 (03): : 785 - 795
  • [35] Vildagliptin efficacy and safety in patients with type 2 diabetes inadequately controlled on dual metformin plus sulfonylurea therapy
    Lukashevich, V.
    Wang, M.
    Del Prato, S.
    Araga, M.
    Kothny, W.
    DIABETOLOGIA, 2012, 55 : S353 - S353
  • [36] Efficacy and safety of linagliptin as add-on therapy to basal insulin and metformin in people with Type 2 diabetes
    Duran-Garcia, S.
    Lee, J.
    Yki-Jarvinen, H.
    Rosenstock, J.
    Hehnke, U.
    Thiemann, S.
    Patel, S.
    Woerle, H. -J.
    DIABETIC MEDICINE, 2016, 33 (07) : 926 - 933
  • [37] Efficacy and safety of saxagliptin and glimepiride in patients with type 2 diabetes inadequately controlled with metformin monotherapy: results from the SPECIFY study
    Gu, T.
    Zhu, L.
    Niu, Q.
    Li, C.
    Bi, Y.
    Zhu, D.
    DIABETOLOGIA, 2018, 61 : S379 - S379
  • [38] A phase 3 trial to evaluate the efficacy and safety of chiglitazar added to metformin in Chinese patients with type 2 diabetes inadequately controlled on metformin monotherapy
    Gao, L.
    Ji, L.
    Dong, X.
    Cheng, Z.
    Zhang, X.
    Sun, W.
    Ma, J.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S359 - S360
  • [39] COMPARISON OF VILDAGLIPTIN AS AN ADD-ON THERAPY AND SULFONYLUREA DOSE-INCREASING THERAPY IN PATIENTS WITH INADEQUATELY CONTROLLED TYPE 2 DIABETES USING METFORMIN AND SULFONYLUREA
    Hong, A. R.
    Lee, J.
    Ku, E. J.
    Hwangbo, Y.
    Kim, K. M.
    Moon, J. H.
    Choi, S. H.
    Jang, H. C.
    Lim, S.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S141 - S141
  • [40] Sustained efficacy of dapagliflozin when added to metformin in type 2 diabetes inadequately controlled by metformin monotherapy
    Bailey, C. J.
    Gross, J. L.
    Yadav, M.
    Iqbal, N.
    Mansfield, T. A.
    List, J. F.
    DIABETOLOGIA, 2011, 54 : S67 - S67
12345